Related Experiment Video
Updated: Aug 10, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
The structural properties and contractile force of a clot
Cell Motility
|January 1, 1982
Summary
Platelet contractility significantly enhances blood clot rigidity. The platelet microfilament system generates force, modulating clot structure and elasticity during hemostasis.
Area of Science:
- Biophysics
- Hematology
- Cell Biology
Background:
- Blood clots form viscoelastic gels upon recalcification of citrated plasma.
- Platelet function is crucial in hemostasis, but the precise relationship between platelet contractility and clot mechanical properties requires further elucidation.
Purpose of the Study:
- To investigate the relationship between platelet contractility and the mechanical properties (rigidity) of blood clots.
- To determine the role of the platelet microfilament system in clot structure formation and force generation.
Main Methods:
- Rheological techniques were employed to simultaneously measure dynamic rigidity modulus and contractile force during clot formation in platelet-rich plasma (PRP).
- Experiments utilized platelet-free plasma (PFP), sonicated PRP, PRP from Glanzmann thrombasthenia patients, and various inhibitors (metabolic, cytochalasin B/E, colchicine, vinblastine) to probe clot mechanics.
- The effect of thrombin-activated, fixed platelets and streptokinase on clot properties was also assessed, alongside external straining of PFP clots.
Main Results:
- Platelet-rich plasma (PRP) clots exhibited significantly higher elastic modulus (6,000 dynes/cm²) and contractile force (1,500 dynes/cm²) compared to platelet-free plasma (PFP) clots (700 dynes/cm² and <100 dynes/cm²).
- Cytochalasin B and E suppressed clot rigidity and force generation in a dose-dependent manner, correlating with actin polymerization inhibition.
- Metabolic inhibitors (2-deoxy-D-glucose, KCN) slowed clotting, while colchicine and vinblastine had no significant effect. Thrombin-activated, fixed platelets did not generate force or increase rigidity. Streptokinase decreased both force and rigidity.
Conclusions:
- Clot structure formation in PRP is intrinsically linked to the contractile force generated by the platelet microfilament system.
- Platelet-derived contractile force plays a critical role in modulating the overall rigidity and mechanical integrity of blood clots.
- Understanding this coupling is essential for comprehending hemostasis and developing targeted therapies for bleeding or thrombotic disorders.
Related Concept Videos
01:13Cell-matrix's Response to Mechanical Forces
In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue.
Anchoring junctions mechanically attach a cell to the...
Anchoring junctions mechanically attach a cell to the...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.